Praphulla Chandra Shukla

2.3k total citations
39 papers, 1.8k citations indexed

About

Praphulla Chandra Shukla is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Praphulla Chandra Shukla has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 8 papers in Cancer Research. Recurrent topics in Praphulla Chandra Shukla's work include CRISPR and Genetic Engineering (5 papers), MicroRNA in disease regulation (4 papers) and PARP inhibition in cancer therapy (4 papers). Praphulla Chandra Shukla is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), MicroRNA in disease regulation (4 papers) and PARP inhibition in cancer therapy (4 papers). Praphulla Chandra Shukla collaborates with scholars based in India, Canada and Saudi Arabia. Praphulla Chandra Shukla's co-authors include Subodh Verma, Adrian Quan, Fina Lovren, Hwee Teoh, Mohammed Al‐Omran, Krishna K. Singh, Yi Pan, Milan Gupta, Mark D. Peterson and Yi Pan and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Praphulla Chandra Shukla

35 papers receiving 1.7k citations

Peers

Praphulla Chandra Shukla
Bo Ding China
Romain Harmancey United States
Yi Pan Canada
Ali Javaheri United States
Praphulla Chandra Shukla
Citations per year, relative to Praphulla Chandra Shukla Praphulla Chandra Shukla (= 1×) peers Philipp Stawowy

Countries citing papers authored by Praphulla Chandra Shukla

Since Specialization
Citations

This map shows the geographic impact of Praphulla Chandra Shukla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Praphulla Chandra Shukla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Praphulla Chandra Shukla more than expected).

Fields of papers citing papers by Praphulla Chandra Shukla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Praphulla Chandra Shukla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Praphulla Chandra Shukla. The network helps show where Praphulla Chandra Shukla may publish in the future.

Co-authorship network of co-authors of Praphulla Chandra Shukla

This figure shows the co-authorship network connecting the top 25 collaborators of Praphulla Chandra Shukla. A scholar is included among the top collaborators of Praphulla Chandra Shukla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Praphulla Chandra Shukla. Praphulla Chandra Shukla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Vivek, Praveen Vashist, Noopur Gupta, et al.. (2025). Burden of blindness and visual impairment associated with corneal opacities in India. British Journal of Ophthalmology. 109(7). 829–836.
2.
Chakrabarti, Rituparna, et al.. (2025). Vitamin D attenuates PCSK9-driven phenotypic switch of vascular smooth muscle cells and neointimal hyperplasia via SIRT6 activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1872(3). 168135–168135.
3.
Shukla, Praphulla Chandra, et al.. (2025). The endothelium at the crossroads of multi-organ pathology: Insights from organ-on-chip models. Vascular Pharmacology. 161. 107551–107551.
4.
Chakrabarti, Rituparna, et al.. (2024). New epigenome players in the regulation of PCSK9-H3K4me3 and H3K9ac alterations by statin in hypercholesterolemia. Journal of Lipid Research. 66(1). 100699–100699. 6 indexed citations
5.
Chakrabarti, Rituparna, et al.. (2024). Gene editing and therapy in acquired and inherited cardiovascular disorders. The Nucleus. 67(1). 237–250. 1 indexed citations
6.
Dolai, Tuphan Kanti, et al.. (2023). Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review. SHILAP Revista de lepidopterología. 13(3). 179–194. 3 indexed citations
7.
Chakrabarti, Rituparna, et al.. (2023). Natural Killer T cells and the invariant subset promote atherosclerosis: A meta-analysis. Life Sciences. 321. 121620–121620. 2 indexed citations
8.
Lazarow, Katina, Praphulla Chandra Shukla, Vanasa Nageswaran, et al.. (2023). Large-scale microRNA functional high-throughput screening identifies miR-515-3p and miR-519e-3p as inducers of human cardiomyocyte proliferation. iScience. 26(5). 106593–106593. 2 indexed citations
9.
Mukherjee, Budhaditya, et al.. (2022). Exploring the crosstalk between long non-coding RNAs and microRNAs to unravel potential prognostic and therapeutic biomarkers in β-thalassemia. Molecular Biology Reports. 49(7). 7057–7068. 6 indexed citations
10.
Bhattacharya, Anindita, et al.. (2021). Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(1). 188581–188581. 43 indexed citations
11.
Thompson, Melissa D., Yu Mei, Robert M. Weisbrod, et al.. (2014). Glutathione Adducts on Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase Cys-674 Regulate Endothelial Cell Calcium Stores and Angiogenic Function as Well as Promote Ischemic Blood Flow Recovery. Journal of Biological Chemistry. 289(29). 19907–19916. 51 indexed citations
12.
Singh, Krishna K., Praphulla Chandra Shukla, Adrian Quan, et al.. (2013). BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis. Journal of Thoracic and Cardiovascular Surgery. 146(4). 949–960.e4. 54 indexed citations
13.
Singh, Krishna K., Praphulla Chandra Shukla, Bobby Yanagawa, et al.. (2013). Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1. Journal of Thoracic and Cardiovascular Surgery. 146(3). 702–709. 22 indexed citations
14.
Teoh, Hwee, Adrian Quan, K. W. Annie Bang, et al.. (2012). BRCA1 gene therapy reduces systemic inflammatory response and multiple organ failure and improves survival in experimental sepsis. Gene Therapy. 20(1). 51–61. 21 indexed citations
15.
Shukla, Praphulla Chandra, Krishna K. Singh, Adrian Quan, et al.. (2011). BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nature Communications. 2(1). 593–593. 115 indexed citations
16.
Singh, Krishna K., Praphulla Chandra Shukla, Adrian Quan, et al.. (2011). BRCA2 Protein Deficiency Exaggerates Doxorubicin-induced Cardiomyocyte Apoptosis and Cardiac Failure. Journal of Biological Chemistry. 287(9). 6604–6614. 44 indexed citations
17.
Shukla, Praphulla Chandra, Fina Lovren, Yi Pan, et al.. (2011). Abstract 11544: MicroRNA-145 Targeted Therapy Reduces Atherosclerosis and Improves Plaque Stability. Circulation. 124(suppl_21). 1 indexed citations
18.
Shukla, Praphulla Chandra, Krishna K. Singh, Bobby Yanagawa, Hwee Teoh, & Subodh Verma. (2010). DNA damage repair and cardiovascular diseases. Canadian Journal of Cardiology. 26. 13A–16A. 37 indexed citations
19.
Lovren, Fina, Yi Pan, Praphulla Chandra Shukla, et al.. (2009). Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. American Journal of Physiology-Endocrinology and Metabolism. 296(6). E1440–E1449. 98 indexed citations
20.
Singh, Krishna K., et al.. (2008). Conservation of 5′-upstream region of the FBN1 gene in primates. European Journal of Human Genetics. 16(7). 869–872. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026